4 unknown, 3 completed, 2 not yet recruiting, 1 active not recruiting. 12 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 12 | Unknown 4, Completed 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Recruiting 1 |
Follow tegoprazan: new trials by email Literature Review of tegoprazan trials Research Report on tegoprazan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERD Tegoprazan 50 mg, Placebo - GERD (Gastroesophageal Reflux Disease) | Phase 4 | Not yet recruiting | HK inno.N Corporation | 100 | 2026-09-01 | 2026-09-17 |
| Tegoprazan Plus Amoxicillin BID vs TID Regimens for H. Pylori Eradication（Frequency Adjusted Same-dose Therapy for H. Pylori） Tegoprazan 50 mg, Amoxicillin 1 g TID, Amoxicillin 1.5 g BID - HELICOBACTER PYLORI INFECTIONS | Phase 4 | Not yet recruiting | First People's Hospital of Hangzhou | 240 | 2025-11-20 | 2025-11-21 |
| Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia Tegoprazan, Famotidine, Placebo - General Anesthesia | Phase 4 | Enrolling by invitation | Seok Kyeong Oh | 174 | 2025-07-23 | 2025-09-05 |
| Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment tegoprazan, Minocycline, bismuth potassium citrate - Helicobacter Pylori Infection Chronic Gastrit | Phase 4 | Active not recruiting | Xijing Hospital of Digestive Diseases | 208 | 2024-11-11 | 2025-07-03 |
| Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole Tegoprazan, Pantoprazole - Gastroesophageal Reflux Disease | Phase 4 | Recruiting | Carnot Laboratories | 128 | 2024-07-30 | 2025-07-23 |
| Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole Tegoprazan, Esomeprazole 40mg - Helicobacter Pylori Infection | Phase 4 | Unknown | Hospital General de México Dr. Eduardo Liceaga | 160 | 2024-04-19 | 2024-03-19 |
| Tegoprazan-Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for H. Pylori Infection (TATH-1) Tegoprazan 50 mg, tablets, orally, qd, Esomeprazole 20mg BID, Tegoprazan 50 mg, tablets, orally, bid - Helicobacter Pylori Infection | Phase 4 | Completed | Zhang Xiaofeng,MD | 370 | 2023-11-01 | 2026-01-16 |
| A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn Tegoprazan, Esomeprazole - Gastroesophageal Reflux Disease | Phase 4 | Unknown | HK inno.N Corporation | 338 | 2023-03-24 | 2023-08-03 |
| 14-day Double Therapy Versus Bismuth Quadruple Therapy in First-line Treatment of Helicobacter Pylori Infection 14-day high-dose Tegoprazan Dual Therapy (HDDT) - Helicobacter Pylori Infection | Phase 4 | Unknown | Shandong University | 258 | 2023-02-14 | 2023-02-14 |
| Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease Tegoprazan 50mg QD, Lansoprazole 30mg QD - Erosive Reflux Disease | Phase 4 | Completed | HK inno.N Corporation | 218 | 2021-02-16 | 2022-07-29 |
| Change of Gut Microbiome and Symptom After H.Pylori Eradication Therapy in Patients With Functional Dyspepsia Tegoprazan 50mg bid + amoxicillin 1000mg bid + clarithromycin 500mg bid for 10 days - Dyspepsia | Phase 4 | Unknown | Asan Medical Center | 60 | 2020-06-30 | 2020-06-26 |
| Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance Tegoprazan, Esomeprazole - Erosive Reflux Disease | Phase 4 | Completed | HK inno.N Corporation | 46 | 2020-05-22 | 2022-02-25 |
Gastroesophageal Reflux (3) · Dyspepsia (1)
HK inno.N Corporation (4) · Asan Medical Center (1) · Carnot Laboratories (1) · First People's Hospital of Hangzhou (1) · Hospital General de México Dr. Eduardo Liceaga (1) · Seok Kyeong Oh (1) · Shandong University (1) · Xijing Hospital of Digestive Diseases (1) · Zhang Xiaofeng,MD (1)
China (4) · South Korea (4) · Mexico (1)
Sang Kil Lee, Ph.D (2) · Do Hoon Kim (1) · Jose M Remes-Troche, Dr (1) · Kee Wook Jung, MD, PhD (1) · Suk Chae Choi (1) · Xiuli Zuo (1) · Yoali M Velasco Santiago (1) · Yongquan Shi, (1)